HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECHA Publishes Toluene Evaluation; New Exposure Limits Recommended

This article was originally published in The Rose Sheet

Executive Summary

A substance evaluation on toluene conducted under the European Union’s REACH program affirms previous risk assessments but recommends another look at exposure limits in the workplace.

You may also be interested in...



ECHA Proposes Oxybenzone, Glycolic Acid For Next REACH Review

Sunscreen agent oxybenzone and cosmetic ingredient glycolic acid are among ECHA’s latest nominees for evaluation under REACH.

ECHA Proposes Formaldehyde, Ti02 Among Substances For REACH Evaluation

The European Chemicals Agency has released a first draft list of substances that could be subject to review under the Registration, Evaluation, Authorization and Restriction of Chemicals substance evaluation process.

Women’s Voices For The Earth Will Keep After CIR, Salon Worker Safety In 2024

Women’s Voices for the Earth continues to call attention to cosmetic ingredients’ potential health impacts on users including salon workers, while pushing the Cosmetic Ingredient Review to consider a wider variety of safety information in its assessment work.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018866

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel